Globus Medical Inc
GMED· NYSE
Released Feb 20, 2025, after the close
10-K filed Feb 20, 2025, 51 days after period end · 0001562762-25-000026
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $657.29M | $616.53M | $274.50M | $250.02M |
| Net Income | $26.51M |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $15.03M |
| $50.06M |
| $15.11M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.